Related Experiment Video

Updated: May 31, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients

G Konjevic1, S Radenkovic, T Srdic

  • 1Institute of Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia. konjevicg@ncrc.ac.rs

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|July 19, 2011
PubMed
Abstract

Insights

Breast cancer patients show reduced interferon-gamma (IFNγ) and impaired natural killer (NK) cell function, linked to lower pSTAT1 signaling. This suggests pSTAT1 may indicate reduced NK cell activity and IFNγ levels in breast cancer progression.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Signaling

Background:

  • Impaired interferon-gamma (IFNγ) production in peripheral blood lymphocytes (PBL) signifies immunosuppression and inadequate antitumor responses in cancer patients.
  • Natural killer (NK) cell dysfunction in breast cancer, particularly concerning signal transducer and activator of transcription (STAT) signaling pathways, remains under-investigated.

Purpose of the Study:

  • To investigate the relationship between impaired IFNγ production, NK cell activity, and pSTAT signaling pathways in breast cancer patients.
  • To determine if pSTAT1 levels in PBL correlate with NK cell cytotoxicity and IFNγ levels in breast cancer.

Main Methods:

  • Peripheral blood lymphocytes (PBL) from breast cancer patients and healthy controls were analyzed for IFNγ and pSTAT1 expression.
  • NK cell activity was assessed using the (51)Cr-release assay.
  • pSTAT1, pSTAT3, and pSTAT5 levels were quantified by Western blotting.

Main Results:

  • Patients exhibited significantly lower levels of IFNγ in PBL and NK cells, along with decreased NK cell cytotoxicity, correlating with disease stage.
  • A positive correlation was observed between IFNγ levels and NK cell cytotoxicity in both patients and controls.
  • PBL from patients showed reduced expression of pSTAT1, pSTAT3, and pSTAT5 compared to controls, with lower pSTAT1 in T and NK cell subsets.

Conclusions:

  • Reduced pSTAT1 levels in PBL of breast cancer patients are associated with diminished NK cell cytotoxicity and IFNγ levels.
  • pSTAT1 may serve as a potential biomarker for decreased NK cell function and IFNγ production, reflecting disease progression in breast cancer.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...